203 related articles for article (PubMed ID: 26782415)
1. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
3. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
4. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
5. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
7. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.
Batsi O; Giannopoulou I; Nesseris I; Valavanis C; Gakiopoulou H; Patsouris ES; Arapandoni-Dadioti P; Lazaris AC
Anticancer Res; 2014 Jul; 34(7):3537-42. PubMed ID: 24982366
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of chemokine CXCL12 and receptor CXCR4 in adenomyosis].
Wang S; Duan H; Li BH; Wang YY; Huang JH; Guo ZC
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):754-759. PubMed ID: 33228346
[No Abstract] [Full Text] [Related]
10. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells.
Retz MM; Sidhu SS; Blaveri E; Kerr SC; Dolganov GM; Lehmann J; Carroll P; Simko J; Waldman FM; Basbaum C
Int J Cancer; 2005 Mar; 114(2):182-9. PubMed ID: 15540205
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
Shen HB; Gu ZQ; Jian K; Qi J
Tumour Biol; 2013 Jun; 34(3):1839-45. PubMed ID: 23526079
[TBL] [Abstract][Full Text] [Related]
12. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
14. Expression Patterns of CXCL12 and its Receptor in Colorectal Carcinoma.
Mousavi A; Hashemzadeh S; Bahrami T; Estiar MA; Feizi MAH; Pouladi N; Rostamizadeh L; Sakhinia E
Clin Lab; 2018 May; 64(5):871-876. PubMed ID: 29739049
[TBL] [Abstract][Full Text] [Related]
15. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
16. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
[TBL] [Abstract][Full Text] [Related]
17. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.
de Oliveira KB; Guembarovski RL; Guembarovski AM; da Silva do Amaral Herrera AC; Sobrinho WJ; Ariza CB; Watanabe MA
Clin Exp Med; 2013 Aug; 13(3):211-9. PubMed ID: 22699677
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer.
Eisenhardt A; Frey U; Tack M; Rosskopf D; Lümmen G; Rübben H; Siffert W
Eur Urol; 2005 Jan; 47(1):111-7. PubMed ID: 15582259
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
Huang Y; Li DJ; Wang MY; Cheng HD
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of SDF-1 isoforms in bladder cancer.
Gosalbez M; Hupe MC; Lokeshwar SD; Yates TJ; Shields J; Veerapen MK; Merseburger AS; Rosser CJ; Soloway MS; Lokeshwar VB
J Urol; 2014 Jun; 191(6):1899-1905. PubMed ID: 24291546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
